The Cardiology Seminal Trial's series is well underway

Please do read the seminal trials. You will learn stuff that you likely did not know. Stuff that does not make the colored boxes in guidelines.

With age, I have come to appreciate the value of reading and knowing the evidence underpinning what we do in cardiology.

The thing is that cardiology requires a lot of technical learning. To read images or perform procedures, you have to master specific tasks. Forging these neural pathways takes a lot of effort and time, especially for new learners. This leaves little time to understand the evidence underpinning why—exactly—we learn these specific tasks.

And that is where the understanding of the seminal trials comes in. I often advise young learners to break away from, say, learning how to measure the left atrial appendage, and spend some time reading the seminal trials.

Reading only the guidelines is not enough, because guideline documents are merely one group’s take of the seminal trials.

My friend and colleague Andrew Foy had this grand idea to write a book in which we chronicle the seminal trials. We enlisted the help of Mohammed Ruzieh, a trainee of Foy, and now an academic cardiologist at the University of Florida.

We started writing in a Google Doc. Then we had the idea that we would write it on Substack. We group trials by topic.

We have recently finished the first section on myocardial infarction.

The Substack is called Cardiology Trials. The index of MI trials is here.

Here is the summary post on the MI trials. The vast majority of the content, including podcasts, are free.

Thanks for reading and supporting our efforts.